We are excited to announce a recent addition to our rapidly expanding team: Krisztina Nemenyi has joined as our Vice President Regulatory Affairs.

Krisztina joined Tagworks Pharmaceuticals from Cyteir Therapeutics where she served as Head of Regulatory Affairs and Quality. Prior to Cyteir, Krisztina worked at Takeda Pharmaceuticals for seven years. During her tenure at Takeda, she has held various positions; VP, Global Program Lead for Oncology, Head of Global Regulatory Affairs, Oncology, as well as Vice President of Global Regulatory Affairs, Emerging Markets and Marketed Products located in Singapore. Prior to joining Takeda, Ms. Nemenyi spent eight years at Bristol Myers Squibb, first as Director Regulatory, Oncology, leading a broad spectrum of the oncology portfolio, then as Head of Asia-Pacific, Global Regulatory Affairs located in South Korea. She also held regulatory positions with increasing responsibilities at Baxter and Bayer Pharmaceuticals.

Ms. Nemenyi received her MS in chemical engineering, biochemistry from the Technical University of Budapest, Hungary, and her Ph.D. in chemical engineering and environmental chemistry from the Technical University of Vienna, Austria.

The expertise of Ms. Nemenyi enables Tagworks in the ambition to develop a pipeline of first-in-class Click-to-Release therapeutics to change the standard of care for patients suffering from severe diseases including cancer.

We feel privileged to welcome Krisztina to Tagworks Pharmaceuticals!